Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy

Journal of Virology

Volumn 67, Issue 9, 1993, Pages 5353-5359

  Balzarini, J ^a   Karlsson, A ^a   Perez Perez, M J ^a   Camarasa, M J ^a   Tarpley, W G ^a   De Clercq, E ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(4,7 DICHLORO 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; 9 CHLORO 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; ANTIVIRUS AGENT; BHAP; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; U 88204E; UNCLASSIFIED DRUG; ZIDOVUDINE; [1 [2',5' BIS O (TERT BUTYLDIMETHYLSILYL) BETA D RIBOFURANOSYL] 3 METHYLTHYMINE] 3' SPIRO 5'' (4'' AMINO 1'',2'' OXATHIOLE 2'',2'' DIOXIDE);

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS MUTATION;

EID: 0027214433     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.67.9.5353-5359.1993     Document Type: Article

References (0)